New therapeutic target for colorectal cancer has been identified
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
List view / Grid view
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
27 April 2015 | By Victoria White
Preclinical data from Synthetic Biologics’ novel SYN-005 programme for the treatment of Pertussis were presented in two posters at ECCMID 2015...
24 April 2015 | By Victoria White
arGEN-X and de Duve Institute/UCL/WELBIO have announced the publication of new data showing that ARGX-115 blocks the activity of GARP...
23 April 2015 | By Victoria White
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory osteolysis (bone breakdown)...
23 April 2015 | By Victoria White
Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...
23 April 2015 | By Thermo Fisher Scientific
The Thermo Scientific Multidrop Combi is a reagent dispenser offering unrivalled levels of flexibility and performance to meet the requirements of reagent dispensing in pharmaceutical and biotechnology laboratories...
23 April 2015 | By Thermo Fisher Scientific
The Thermo Scientific Varioskan LUX Multimode Microplate Reader is designed for bioscience researchers with a wide variety of needs...
23 April 2015 | By Victoria White
An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...
22 April 2015 | By Victoria White
New preclinical data demonstrates that mAbXcite therapies causes an immune cascade that successfully recruits T-cells to mount an attack against cancer...
22 April 2015 | By Victoria White
Blend Therapeutics has presented preclinical data on it's lead product candidate, BTP-114, a novel personalised cisplatin prodrug, at AACR 2015...
22 April 2015 | By Victoria White
ARIAD has announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), at AACR 2015...
22 April 2015 | By Victoria White
Astellas and Potenza have entered an exclusive R&D collaboration. The agreement includes an option for the future acquisition of Potenza by Astellas...
21 April 2015 | By Victoria White
Epizyme has presented data on two epigenetic targets, CARM1 and PRMT6, in its pioneering therapeutic pipeline at the AACR Annual Meeting 2015...
21 April 2015 | By Victoria White
Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...